Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Dihydroartemisinin-Piperaquine in Children with Malaria
NCT00845533Phase 4Completed
- Sponsor
- University of California, San Francisco
- Start
- Aug 2007
- Primary completion
- Dec 2007
- Modality
- Bivalent/Multivalent Binders, Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
01
Overview
A Phase 4 trial of dihydroartemisinin + piperaquine in malaria, sponsored by University of California, San Francisco. Started Aug 2007; status: completed.
02
Drugs
dihydroartemisinin + piperaquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT00845533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00845533.